Paper Details

  1. Home
  2. Paper Details

Holding chambers versus nebulisers for beta-agonist treatment of acute asthma.

Author: BaraA, CatesC C J, CrillyJ A, RoweB H

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

While nebulizers are commonly used for asthma attacks, inhalers with spacers might be just as effective. Nebulizers are more expensive, require electricity, and need regular cleaning, making inhalers with spacers a potentially more practical option outside of hospitals.
Paper Details　
Original Abstract of the Article :
In acute asthma inhaled beta-2-agonists are often administered to relieve bronchospasm by wet nebulisation, but some have argued that metered-dose inhalers with a holding chamber (spacer) can be equally effective. In the community setting nebulisers are more expensive, require a power source and nee...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD000052

データ提供：米国国立医学図書館（NLM）

Holding Chambers vs. Nebulisers for Acute Asthma Treatment

This research takes us into the world of respiratory medicine, specifically exploring the use of holding chambers versus nebulisers for delivering beta-agonist treatment to patients experiencing acute asthma. Much like a camel seeking a cool oasis in a scorching desert, individuals experiencing an asthma attack need fast and effective relief. The authors delve into the debate surrounding the effectiveness and practicality of these two delivery methods, seeking to identify the optimal approach for treating acute asthma. This research aims to provide valuable insights for healthcare professionals and patients alike.

Holding Chambers Show Promise for Treating Acute Asthma

The authors discuss the use of holding chambers as an effective alternative to nebulisers for delivering beta-agonist treatment to patients with acute asthma. This research suggests that holding chambers may be just as effective as nebulisers in relieving bronchospasm, while offering a more convenient and cost-effective option. This study highlights the potential benefits of using holding chambers in the management of acute asthma.

Navigating the Desert of Respiratory Challenges

Asthma is a common and potentially life-threatening condition. This research provides valuable insights into the use of holding chambers as a practical and effective alternative to nebulisers for treating acute asthma. By understanding the benefits of each delivery method, healthcare professionals can tailor treatment approaches to meet the individual needs of their patients. Just as a camel navigates the unpredictable desert landscape, individuals with asthma can navigate their respiratory challenges with the right tools and knowledge.

Dr. Camel's Conclusion

This study raises the question of whether holding chambers can be as effective as nebulisers in delivering beta-agonist treatment for acute asthma. The potential benefits of holding chambers, including convenience and cost-effectiveness, warrant further research and consideration in the management of acute asthma.

Date :
  1. Date Completed 2003-09-25
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

12917881

DOI: Digital Object Identifier

10.1002/14651858.CD000052

Related Literature

Article Analysis
・Effective treatment of asthma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.